AstraZeneca to acquire EsoBiotec to advance cell therapy ambition
EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cell therapy
Immuneel sets up cell therapy development and production facility in Narayana Hrudayalaya Health…
The facility will currently focus on autologous cell therapies including CAR-T cell therapy for lymphomas and leukaemias
ImmunityBio and NantKwest announce merger
Merged entity brings together 11 Phase II / III clinical trials across oncology and infectious disease that use combined…
Regenerative medicine market to reach $16.4 bn in 2026: GlobalData
There are currently 53 marketed RM products and 175 RM pipeline agents in development in the eight major markets
Only 152 CMOs are equipped to manufacture cell and gene therapies: GlobalData
Production bottlenecks are the major obstacle to large-scale commercial manufacture once more advanced therapy medicinal products…
Merck acquires FloDesign Sonics, of Wilbraham, Massachusetts, USA
The acquisition is strategic fit for Merck, strengthening ability alongside pharmaceutical manufacturers to advance cell-based…